X0306 4 2022-05-11 0 0001689657 Berkeley Lights, Inc. BLI 0001817415 Hobbs Eric C/O BERKELEY LIGHTS, INC. 5858 HORTON STREET, SUITE 320 EMERYVILLE CA 94608 0 1 0 0 see Remarks Common Stock 2022-05-11 4 M 0 1302 0.64 A 373829 D Common Stock 2022-05-11 4 M 0 37500 0.64 A 411329 D Common Stock 2022-05-11 4 S 0 98011 4.1785 D 313318 D Common Stock 2022-05-12 4 S 0 123062 4.3057 D 190256 D Common Stock 2022-05-13 4 S 0 7531 4.97 D 182725 D Stock Option (Right to Buy) 0.64 2022-05-11 4 M 0 1302 0 D 2024-10-13 Common Stock 1302 0 D Stock Option (Right to Buy) 0.64 2022-05-11 4 M 0 37500 0 D 2025-02-12 Common Stock 37500 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.66. The reporting person undertakes to provide Berkeley Lights, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.50. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option is currently exercisable. President - Antibody Therapeutics /s/ Christine Nassi, Attorney-in-fact for Eric Hobbs 2022-05-13